Comparison of the antiviral effect of Arbidol and Chloroquine in treating COVID-19 | Zendy

Ming Li | Zendy; Tongya Yu | Zendy; Jinghua Zhu | Zendy; Yinjia Wang | Zendy; Yanxia Yang | Zendy; Kaiwu Zhao | Zendy; Yongning Yi | Zendy; Juan He | Zendy; Chao Li | Zendy; Jian He | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparison of the antiviral effect of Arbidol and Chloroquine in treating COVID-19

Author(s) -

Ming Li,

Tongya Yu,

Jinghua Zhu,

Yinjia Wang,

Yanxia Yang,

Kaiwu Zhao,

Yongning Yi,

Juan He,

Chao Li,

Jian He

Publication year - 2021

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.546

H-Index - 19

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-21-400

Subject(s) - chloroquine , medicine , covid-19 , adverse effect , coronavirus , antiviral treatment , virology , virus , disease , immunology , infectious disease (medical specialty) , malaria , chronic hepatitis

The novel coronavirus disease 2019 (COVID-19) was broken out in December 2019 and soon became a global health emergency. Effective treatment for COVID-19 is urgently needed. In the present study, we aimed to evaluate the antiviral effect of Arbidol vs. Chloroquine in treating COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research